Physician Assistant Program year 2025 Reported 2023–2025 Source: CMS Open Payments, 2026 publication

Susan Hartmann

Physician Assistant, Surgical Anchorage, AK Physician Assistant

NPI 1104555408 CMS profile 11398041

4100 Lake Otis Pkwy Ste 320, Ste 400, Anchorage, AK 99508

Open in the dashboard

General payments

$5,499

56 records reported · program years 2023–2025

Research payments

$0

Paid to them · None reported · program years 2023–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Susan Hartmann of Anchorage, AK is reported in the CMS Open Payments database as having received $5,499 across 56 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Physician Assistant, Surgical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,984 31
2024 General $3,275 18
2023 General $240 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Susan Hartmann
  • Physician Assistant, Surgical median
  • Middle half of Physician Assistant, Surgical
  • National median

In program year 2025, general payments to Susan Hartmann were reported at $1,984. Among 8,152 Physician Assistant, Surgical profiles paid that year, the median was $146 and the middle half received between $51 and $385.

Show as a table
Year Susan Hartmann Physician Assistant, Surgical median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $0 $111 $36–$285 $132
2022 $0 $126 $44–$350 $149
2023 $240 $137 $47–$355 $160
2024 $3,275 $146 $49–$384 $164
2025 $1,984 $146 $51–$385 $169

Breakdown

Who paid General payments · program years 2023–2025
  1. Medical Device Business Services, Inc. $1,780 8 payments
  2. Medtronic, Inc. $1,684 26 payments
  3. SI-BONE, Inc. $1,471 7 payments
  4. Globus Medical, Inc. $193 3 payments
  5. Merz Pharmaceuticals, LLC $118 2 payments
  6. Ethicon US, LLC $92 3 payments
  7. Baxter Healthcare $73 1 payment
  8. Nevro Corp. $50 3 payments
  9. Neurelis, Inc. $19 1 payment
  10. GT Medical Technologies, Inc $19 2 payments

Every payment, record by record

What the payments were for General payments · program years 2023–2025
  1. Travel and Lodging $3,626 17 payments
  2. Food and Beverage $1,788 38 payments
  3. Education $85 1 payment
Products named General payments · program years 2023–2025
  1. STRATAFIX $1,795 10 payments
  2. IFUSE IMPLANT SYSTEM $1,251 5 payments
  3. CD HORIZON SPINAL SYSTEM $1,219 20 payments
  4. PLASMABLADE(TM) $207 1 payment
  5. INCEPTIV $164 2 payments
  6. TLIF $150 1 payment
  7. RISE $150 1 payment
  8. VISTASEAL $101 2 payments
  9. EXCELSIUS GPS $86 4 payments
  10. INFINITY OCCIPITOCERVICAL UPPER THORACIC SYSTEM $73 1 payment
  11. Other $352 14 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

181

Median for Physician Assistant: 241

Drug cost

$1,734

Median for Physician Assistant: $4,110

Branded share of claims

6.1%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 26 $475
Oxycodone Hcl Generic 41 $310
Cyclobenzaprine Hcl Generic 21 $219
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 11 $163
Pregabalin Generic 13 $163
Methocarbamol Generic 17 $150
Methylprednisolone Generic 14 $120
Doxycycline Hyclate Generic 14 $72
Tramadol Hcl Generic 24 $61

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 68 billing codes

Paid by Medicare

$52,257

Medicare's payments for the services billed

Medicare patients

182

Average age 71

Services billed

627

115 women, 67 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 73%
Depression 29%
Diabetes 27%
Ischemic heart disease 27%
Chronic kidney disease 20%
Heart failure 16%
Atrial fibrillation 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

56 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record